Sinocare Inc. (300298.SZ) SHZ
16.20
+1.52588e-7(+0.00%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
16.20
+1.52588e-7(+0.00%)
Currency In CNY
Sector
Healthcare
Industry
Medical - Devices
Employees
4809
First IPO Date
March 19, 2012
| Name | Title | Pay | Year Born |
| Bo Tan | Accounting Supervisor | 0 | N/A |
| Huiyu Xu | Securities Affairs Representative | 0 | N/A |
| Baishen Ouyang | Chairman of the Supervisory Board & Assistant to the GM | 0 | 1978 |
| Chungeng Chen | Supervisor & Supply Chain Director | 0 | 1977 |
| Jianwen Cai | Deputy General Manager | 0 | 1974 |
| Shi Min Wang | Deputy General Manager | 0 | 1969 |
| Shao Bo Li | Chairman & GM | 0 | 1965 |
| Zhuzi He | Financial Director | 0 | 1974 |
| Jiyun Zheng | Deputy GM & Board Secretary | 0 | 1987 |
Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.